Roche Jumps Back Into Huntington’s With Spark/NeuExcell Partnership
Executive Summary
Deal Snapshot: Roche gene therapy subsidiary Spark gets option and will partner with start-up NeuExcell on a Huntington’s gene therapy that researchers say may regenerate functional neurons.